Advertisement

Topics

Proposed biosimilar drug shows potential as breast cancer treatment

11:45 EST 1 Dec 2016 | Topix

Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published online by JAMA . Biological agents, including monoclonal antibodies, have increased the treatment options and greatly improved outcomes for a number of cancers.

Original Article: Proposed biosimilar drug shows potential as breast cancer treatment

NEXT ARTICLE

More From BioPortfolio on "Proposed biosimilar drug shows potential as breast cancer treatment"

Quick Search
Advertisement